Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis

NCT00760864 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

432

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: TAK-715 and methotrexate
DRUG: TAK-715 and methotrexate
DRUG: TAK-715 and methotrexate
DRUG: Methotrexate

Sponsor

Takeda